204 results
Page 2 of 11
20-F/A
hm4iwhltnoou
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
zap ujqxna05x0r16js6
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.1
7io328ftlo
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.2
bsu4ht
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
6ypa95nds8yg47 agd
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
v650vq
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
1ubwfo1t5p
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.1
st5xtyqas78ullw
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
amtbb8a8y 52p
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
5f468y78
17 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
12:35pm
6-K
EX-99.1
xlpub7kqzq bs
2 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
2:03pm
6-K
EX-99.1
766a8 2msdgf
17 May 22
Replicel Life Sciences Inc. Provides Default Status Update
6:51pm
6-K
EX-99.4
x27vf 7rfl09c
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
ht6wxzf
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.3
um70tbvwg19
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
w4gxa6h9913x7qrw5yck
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
corxc4wg bby
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
4u4kjs62kq4
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.3
z56lb8izddn4k7lbxnj
21 Dec 21
51-102F3 Material Change Report
5:28pm